GlaxoSmithKline shares have been edging lower amid a bribery investigation in China.

Source: http://rss.cnn.com/~r/rss/money_news_international/~3/ylEOtRxHbHQ/index.html

This entry was posted on Wednesday, July 17th, 2013 at 9:58 pm and is filed under Finance/ Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.